Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CohBar Inc CWBR

Healthcare Biotechnology
CohBar, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting chronic and age-related diseases. Its processes of identifying nucleic acid sequences encoding native peptides in the mitochondrial genome, developing and optimizing novel analogs of these natural mitochondrial derived peptides (MDPs) and developing and conducting screens to... see more

Recent & Breaking News (GREY:CWBR)

CohBar Announces the Appointment of Dr. Philippe Calais to its Board

GlobeNewswire June 7, 2018

CohBar to Hold 2018 Annual Shareholder Meeting and Investor Update, June 19, 2018

GlobeNewswire June 6, 2018

CohBar to Present CB4211 Novel Mechanism of Action at American Diabetes Association 78th Scientific Sessions

GlobeNewswire May 29, 2018

CohBar, Inc. Announces First Quarter 2018 Financial Results

GlobeNewswire May 15, 2018

CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange

GlobeNewswire April 18, 2018

CohBar, Inc. Announces Closing of Private Placement for Aggregate Gross Proceeds of Approximately $3,900,000

GlobeNewswire April 13, 2018

CohBar, Inc. Announces Fourth Quarter 2017 Financial Results

GlobeNewswire April 2, 2018

CohBar, Inc. Announces Closing of First Tranche of Private Placement

GlobeNewswire March 29, 2018

CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes

GlobeNewswire March 26, 2018

CohBar, Inc. to Announce 2017 Fourth Quarter Financial Results and Host Conference Call for Shareholders on April 2, 2018

GlobeNewswire March 19, 2018

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

PR Newswire January 16, 2018

CohBar Announces Approval for Listing on the NASDAQ Capital Market

GlobeNewswire December 13, 2017

CohBar Announces the Appointment of Dr. John Amatruda to its Board

GlobeNewswire December 7, 2017

CohBar, Inc. Announces Third Quarter 2017 Financial Results

GlobeNewswire November 13, 2017

CohBar, Inc. to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

GlobeNewswire October 26, 2017

CohBar Presents Preclinical Data on CB4209/CB4211 Program for NASH at the AASLD Liver Meeting® 2017

GlobeNewswire October 23, 2017

CohBar, Inc. Announces Scientific Presentation of CB4209/CB4211 Program for NASH at The AASLD Liver Meeting® 2017

GlobeNewswire October 4, 2017

CohBar to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York on September 12, 2017

GlobeNewswire September 8, 2017

CohBar, Inc. Announces Second Quarter 2017 Financial Results

GlobeNewswire August 14, 2017

CohBar, Inc. to Announce Second Quarter 2017 Financial Results and Host Conference Call for Shareholders on August 14, 2017

GlobeNewswire July 27, 2017